Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 22.7M | 21.3M | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | 18.9M | 8.6M |
| Operating income | -24.9M | -23.6M | -21.7M | -10.4M |
| Non operating interest income | ||||
| Income | — | — | 900K | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | -24.3M | -22.9M | -20.8M | -10.2M |
| Tax provision | — | — | — | — |
| Net income | -24.3M | -22.9M | -20.8M | -10.2M |
| Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Basic average shares | 2.0B | 1.8B | 1.8B | 931.1M |
| Diluted average shares | 2.0B | 1.8B | 2.6B | 1.1B |
| EBITDA | -24.9M | -23.6M | -21.7M | -10.4M |
| Net income from continuing op. | -24.3M | -22.9M | -20.7M | -10.2M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |